Sagimet Biosciences Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-10.8M | $-10.8M | — | — |
| Jun 2022 | $-3.0K | $-3.0K | — | — |
| Sep 2022 | $-6.2M | $-6.2M | — | — |
| Dec 2022 | $-7.5M | $-7.5M | — | — |
| Mar 2023 | $-7.1M | $-7.1M | — | $767.0K |
| Jun 2023 | $-5.7M | $-5.7M | — | $1.1M |
| Sep 2023 | $-3.9M | $-3.9M | — | $1.9M |
| Dec 2023 | $-7.1M | $-7.1M | — | $1.3M |
| Mar 2024 | $-6.2M | $-6.2M | — | $759.0K |
| Jun 2024 | $-5.6M | $-5.6M | — | $1.4M |
| Sep 2024 | $-19.6M | $-19.6M | — | $1.5M |
| Dec 2024 | $-11.0M | $-11.0M | — | $1.5M |
| Mar 2025 | $-14.5M | $-14.5M | — | $1.5M |
| Jun 2025 | $-9.1M | $-9.1M | — | $1.6M |
| Sep 2025 | $-10.2M | $-10.2M | — | $1.7M |
| Dec 2025 | $-11.8M | $-11.8M | — | $1.7M |
| Mar 2026 | $-8.6M | $-8.6M | — | $1.8M |
| Jun 2026 | $-11.1M | $-11.1M | — | $3.7M |